[artículo] 
inPsychiatric Clinics of North America > Año 2016 - Vol.39 - No.2 (Junio) . - pp. 239-265

Título :	Treatment-resistant schizophrenia
Tipo de documento:	texto impreso
Autores:	Helio Elkis, Autor ; Peter F Buckley, Autor
Fecha de publicación:	2020
Artículo en la página:	pp. 239-265
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Esquizofrenia, Tratamiento, Resistencia
Resumen:	Although treatment-resistant schizophrenia (TRS) was described 50 years ago and has a gold standard treatment with clozapine based on well-defined criteria, there is still a matter of great interest and controversy. In terms of the underlying mechanisms of the development of TRS, progress has been made for the elucidation of the neurochemical mechanisms.
Link:	./index.php?lvl=notice_display&id=24127

[artículo] Treatment-resistant schizophrenia [texto impreso] / Helio Elkis, Autor ; Peter F Buckley, Autor . - 2020 . - pp. 239-265.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Psychiatric Clinics of North America > Año 2016 - Vol.39 - No.2 (Junio) . - pp. 239-265

Palabras clave:	Esquizofrenia, Tratamiento, Resistencia
Resumen:	Although treatment-resistant schizophrenia (TRS) was described 50 years ago and has a gold standard treatment with clozapine based on well-defined criteria, there is still a matter of great interest and controversy. In terms of the underlying mechanisms of the development of TRS, progress has been made for the elucidation of the neurochemical mechanisms.
Link:	./index.php?lvl=notice_display&id=24127